Staphylococcal Septicaemia Complicating Intracavernosal Autoinjection Therapy for Impotence in a Man with Diabetes
- 1 December 1992
- journal article
- case report
- Published by Wiley in Diabetic Medicine
- Vol. 9 (10) , 947-949
- https://doi.org/10.1111/j.1464-5491.1992.tb01737.x
Abstract
Intracavernosal injection of vasoactive drugs is a safe, effective, and commonly used treatment for impotence in diabetic men. In prospective studies infection has rarely occurred. We report a case of life‐threatening Staphylococcal septicaemia complicating this treatment in a 61‐year‐old man with Type 2 diabetes, probably due to a combination of an unsterile technique and drug‐induced priapism. Infection is a potential risk in diabetic men using intracavernosal injection therapy and those offered it should be informed of the importance of a scrupulous sterile technique and the need to seek urgent medical help for decompression if an erection persists for more than 4–6 h.Keywords
This publication has 8 references indexed in Scilit:
- Purulent Corporeal Cavernositis Secondary to Papaverine-Induced PriapismJournal of Urology, 1991
- The results of an intracorporeal papaverine clinicSexual and Marital Therapy, 1991
- Intracavernous Injection Therapy: Analysis of Results and ComplicationsJournal of Urology, 1990
- Side Effects of Self-Administration of Intracavernous Papaverine and Phentolamine for the Treatment of ImpotenceJournal of Urology, 1989
- Intracavernous Injection of Prostaglandin E1 in Impotent MenJournal of Urology, 1988
- Impotence: treatment by autoinjection of vasoactive drugs.BMJ, 1987
- Intracavernous Drug-Induced Erections in the Management of Male Erectile Dysfunction: Experience with 100 PatientsJournal of Urology, 1986
- NEW TREATMENT FOR PRIAPISMThe Lancet, 1984